🔎 Trials Near Me

Pradžia › Virusinės infekcijos

Virusinės infekcijos klinikiniai tyrimai JAV ieško dalyvių

31 tyrimai dėl Virusinės infekcijos ieško dalyvių vietose visoje Jungtinėse Valstijose.

Miestai su daugiausia tyrimų

Pagal valstiją

Nesenai atnaujinti tyrimai

Oficialus tyrimo tekstas (anglų kalba)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT05624450

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07214571

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-09-28 · NCT00006518

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

Renkami dalyviaiStebimasis tyrimas
Amžius nuo 2 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT01011712

A Study of COVID-19 Vaccine(s) in Children and Adults

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07798648

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07013474

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07706686

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07654283

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07565090

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-09-15 · NCT06863142

Viral Infections in Healthy and Immunocompromised Hosts

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
6 Months – 120 Years · Visoms lytims · Atnaujinta 2026-09-14 · NCT01306084

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
2 Months – 115 Years · Visoms lytims · Atnaujinta 2026-09-10 · NCT04419870

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Renkami dalyviai2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-04 · NCT04230356

Donor-Derived Viral Specific T-cells (VSTs)

Renkami dalyviai1/2 fazė
4 Weeks · Visoms lytims · Atnaujinta 2026-09-04 · NCT02048332

Third Party Viral Specific T-cells (VSTs)

Renkami dalyviai2 fazė
2 Days · Visoms lytims · Atnaujinta 2026-09-04 · NCT02532452

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 40 iki 64 · Visoms lytims · Atnaujinta 2026-08-18 · NCT06810934

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-08-07 · NCT07730450

Genetic Studies of Chronic Active Epstein-Barr Disease

Renkami dalyviaiStebimasis tyrimas
Amžius nuo 1 iki 120 · Visoms lytims · Atnaujinta 2026-07-28 · NCT00032513

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Renkami dalyviai1 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-11 · NCT04013802

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Renkami dalyviai1/2 fazė
1 Month – 79 Years · Visoms lytims · Atnaujinta 2026-04-15 · NCT04197596

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

Renkami dalyviai4 fazėLaukiami sveiki savanoriai
6 Months · Visoms lytims · Atnaujinta 2026-03-27 · NCT06585241

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-30 · NCT07110636

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Renkami dalyviai1 fazė
3 Months – 80 Years · Visoms lytims · Atnaujinta 2026-01-26 · NCT04691622

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.